myoD is one of a family of four related basic helix-loop-helix transcr
iption factors involved in the specification and differentiation of sk
eletal muscle. We previously identified a 258-bp distal enhancer that
is sufficient for embryonic activation of myoD and is highly conserved
between humans and mice, In this paper, we show using a modified bisu
lfite deamination/PCR amplification method that the distal myoD enhanc
er is completely unmethylated at all the CpG sites tested in myogenic
cells and a subpopulation of somite cells. Conversely, the distal enha
ncer in nonmuscle cells and tissues is methylated to an average level
of >50% and we find no chromosomes in these tissues with a completely
unmethylated enhancer. We present evidence that demethylation of the d
istal enhancer in somites of mouse embryos precedes myoD transcription
, suggesting that demethylation of the distal enhancer is an active, r
egulated process that is essential for myoD activation. We also show b
y analysis of transgenic mice carrying a human distal enhancer/reporte
r construct in which the three enhancer CpG sites have been mutated th
at methylation of the distal enhancer is not required to prevent preco
cious or ectopic embryonic myoD expression. We propose that a subset o
f somite cells demethylate the distal enhancer in response to specific
developmental signals, thus making the enhancer accessible and able t
o respond to subsequent signals to activate the myoD gene. (C) 1996 Ac
ademic Press, Inc.